HI-TECH PHARMACAL INC
HITK
HITK was delisted on the 16th of April, 2014.
0 hedge funds and large institutions have $0 invested in HI-TECH PHARMACAL INC in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 108 closing their positions.
100% less funds holding
Funds holding: 108 → 0 (-108)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $418M → $0 (-$418M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 108
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$65.3M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$34.1M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$21.8M |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$21.8M |
| 5 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$20.5M |
HITK Hedge Fund Activity: Q2 2014 in Review
0 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in HI-TECH PHARMACAL INC (HITK) for Q2 2014, worth a combined $0 — down 100% from $418M a quarter earlier.
Sellers outnumbered buyers: 108 funds closed out of HITK and 0 opened new positions — a net loss of 108 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was AQR Capital Management, exiting entirely with an estimated $65.3M sold.
- 0 institutional investors held HI-TECH PHARMACAL INC (HITK) as of Q2 2014, down from 108 in Q1 2014.
- Funds reported $0 of HI-TECH PHARMACAL INC stock for Q2 2014, down 100% quarter-over-quarter.
- 0 funds opened new HI-TECH PHARMACAL INC positions in Q2 2014 and 108 closed out, a net change of -108 holders.
- The largest HI-TECH PHARMACAL INC seller in Q2 2014 was AQR Capital Management, an estimated $65.3M sold.
Based on aggregated 13F filings for Q2 2014.